Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Crit Rev Food Sci Nutr ; 53(9): 929-42, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23768185

RESUMO

Overweight and obesity have a major impact on global health; their prevalence has rapidly increased in all industrialized countries in the past few decades and diabetes and hypertension are their direct consequences. Pharmacotherapy provides reinforcement for obesity treatment, but should be an adjunctive support to diet, exercise, and lifestyle modification. At present, only orlistat and sibutramine have been approved by the US Food and Drug Administration for long-term use, but sibutramine was withdrawn for sale by the European Medicines Agency. The development of functional foods for the prevention and/or treatment of obesity suppose an opportunity for the food market and involve the knowledge of the mechanisms of appetite and energy expenditure as well as the metabolic sensation of satiety. Strategies for weight control management affect gut hormones as potential targets for the appetite metabolic regulation, stimulation of energy expenditure (thermogenesis), and modifications in the metabolic activity of the gut microbiota. Functional foods for obesity may also include bioactive fatty acids, phenolic compounds, soybean, plant sterols, dietary calcium, and dietary fiber. This review intends to offer an overview of the present situation of the anti-obesity agents currently used in dietary therapy as well as some functional food ingredients with potentially anti-obesity effects.


Assuntos
Fármacos Antiobesidade/farmacologia , Dieta , Obesidade/dietoterapia , Cálcio da Dieta/uso terapêutico , Ciclobutanos/farmacologia , Fibras na Dieta/uso terapêutico , Metabolismo Energético , Exercício Físico , Ácidos Graxos Insaturados/uso terapêutico , Análise de Alimentos , Manipulação de Alimentos , Humanos , Lactonas/farmacologia , Estilo de Vida , Obesidade/fisiopatologia , Orlistate , Fitosteróis/uso terapêutico , Polifenóis/uso terapêutico , Glycine max/química , Estados Unidos , United States Food and Drug Administration , Redução de Peso
2.
Rev Esp Enferm Dig ; 77(4): 287-9, 1990 Apr.
Artigo em Espanhol | MEDLINE | ID: mdl-2390343

RESUMO

Posterolateral diaphragmatic hernia (Bochdalek's hernia) is an infrequent finding in adult patients. Most of them are asymptomatic. Symptomatic cases present with digestive symptoms. Sometimes the clinical picture is related to the associated congenital malformations and not to the hernia itself. It is more common on the left side and in most of the cases it lacks of hernia sac. Simple radiologic study is the clue for the diagnosis. A case of Bochdalek's hernia in a 85 year-old patient is presented.


Assuntos
Hérnias Diafragmáticas Congênitas , Idoso , Idoso de 80 Anos ou mais , Hérnia Diafragmática/diagnóstico por imagem , Hérnia Diafragmática/patologia , Humanos , Masculino , Radiografia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA